Journal of Inborn Errors of Metabolism and Screening (Mar 2016)

Beta-Ketothiolase Deficiency

  • Elsayed Abdelkreem MD, MSc,
  • Hiroki Otsuka MD,
  • Hideo Sasai MD,
  • Yuka Aoyama PhD,
  • Tomohiro Hori MD, PhD,
  • Mohamed Abd El Aal MD, PhD,
  • Shaimaa Mahmoud MD, PhD,
  • Toshiyuki Fukao MD, PhD

DOI
https://doi.org/10.1177/2326409816636644
Journal volume & issue
Vol. 4

Abstract

Read online

Beta-ketothiolase deficiency is an inherited disorder of ketone body metabolism and isoleucine catabolism. It typically manifests as recurrent ketoacidotic episodes with characteristic abnormalities in the urinary organic acid profile. However, several challenges in the diagnosis of beta-ketothiolase deficiency have been encountered: atypical presentations have been reported and some other disorders, such as succinyl-CoA:3-oxoacid CoA transferase and 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiencies, can mimic the clinical and/or biochemical signs of beta-ketothiolase deficiency. A final diagnosis of beta-ketothiolase deficiency requires an enzymatic assay and/or a molecular analysis, but some caveats must be considered. Despite the reported missed cases, screening programs have successfully identified an increasing number of patients with beta-ketothiolase deficiency. Early diagnosis and management of beta-ketothiolase deficiency will enable prevention of its serious acute and chronic complications and ultimately improve the prognosis.